LCAT and atherosclerosis: While there is growing interest in the role of LCAT and HDL in reducing atherosclerosis, leading to studies on various LCAT-related therapies, including recombinant LCAT and LCAT activation [123, 124], another perspective focuses on triglyceride-rich lipoproteins and low-density lipoprotein in atherosclerosis pathogenesis.